Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Authors Celularity Incorporated -More
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Links ClinicalTrials.gov
Study PDA-002-DFU-003 is a Phase 2, multicenter, randomized, double blind, placebo-controlled, dose range finding study in subjects who have diabetic foot ulcer (DFU) with peripheral arterial disease (PAD). The study will enroll approximately 24 subjects. This study will investigate the hemodynamic effects, clinical efficacy, and safety of 3 monthly intramuscular (IM) injections of PDA-002 in subjects who have DFU with PAD.
Epistemonikos ID: 07b9e007eef0ae5281bdf4ef6add631425adf44d
First added on: May 12, 2024